Stay updated with breaking news from Genome Stability. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Two scientists at the CECAD Cluster of Excellence in Aging Research have developed a method that can determine an organism's biological age with unprecedented precision. Researchers expect new insights into how the environment, nutrition, and therapies influence the aging process.
AstraZeneca and MSD's Lynparza (olaparib) has been approved in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers. The three approvals authorise Lynparza for: maintenance treatment after 1st-line chemotherapy containing bevacizumab (genetical recombination) for patients with homologous recombination repair deficient (HRD) ovarian cancer; the treatment of patients with BRCA gene-mutated (BRCAm) castrate-resistant prostate cancer with distant metastasis (mCRPC); and as maintenance treatment after platinum-based chemotherapy for patients with BRCAm cur...